Gastrointestinal Cancer

Explore the latest updates, including expert interviews and features
Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

Welcome to the Gastrointestinal Cancer Channel!

Catch up on the latest developments in gastrointestinal cancer with VJOncology, featuring exclusive interviews, podcasts, and expert-led roundtable discussions.

Subtypes

Gastric Cancer
Colorectal Cancer
Liver Cancer
Bile Duct Cancer
Pancreatic Cancer
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
2:06
CAMILLA: Phase I/II study of cabozantinib plus durvalumab in advanced GE cancer and GI malignancies
Anwaar Saeed • 13 Nov 2021
1:21
Future directions of CAMILLA trial
Anwaar Saeed • 13 Nov 2021
0:52
Next steps for cabozantinib plus durvalumab in GI cancer
Anwaar Saeed • 13 Nov 2021
View All Videos
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
2:06
CAMILLA: Phase I/II study of cabozantinib plus durvalumab in advanced GE cancer and GI malignancies
Anwaar Saeed • 13 Nov 2021
1:21
Future directions of CAMILLA trial
Anwaar Saeed • 13 Nov 2021
0:52
Next steps for cabozantinib plus durvalumab in GI cancer
Anwaar Saeed • 13 Nov 2021
View All Videos
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
2:06
CAMILLA: Phase I/II study of cabozantinib plus durvalumab in advanced GE cancer and GI malignancies
Anwaar Saeed • 13 Nov 2021
1:21
Future directions of CAMILLA trial
Anwaar Saeed • 13 Nov 2021
0:52
Next steps for cabozantinib plus durvalumab in GI cancer
Anwaar Saeed • 13 Nov 2021
View All Videos
2:42
Current and future treatment options for cholangiocarcinoma
John Bridgewater • 29 Jul 2021
1:52
Molecular testing in the UK
John Bridgewater • 29 Jul 2021
4:24
NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC
Changhoon Yoo • 15 Jun 2021
2:15
Impact of prior systemic therapy on PFS patients enrolled in FIGHT-202
Ghassan Abou-Alfa • 25 Jun 2021
View All Videos
1:03
Latest developments in radiopharmaceutical therapies
Ian A. Wilson • 12 Nov 2021
0:40
1L NALIRIFOX in advanced or metastatic PDAC
Zev Wainberg • 1 Jul 2021
4:03
Phase I/II trial of zenocutuzumab for tumors with NRG1 fusions
Alison M. Schram • 4 Jun 2021
9:02
Preoperative CRT improves overall survival in pancreatic cancer: long-term results of PREOPANC
Casper H. Van Eijck • 17 May 2021
View All Videos

Topics

Immuno-Oncology
CAR-T & Cellular Therapy
Trial Updates
Molecular Profiling
Radiotherapy
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
2:06
CAMILLA: Phase I/II study of cabozantinib plus durvalumab in advanced GE cancer and GI malignancies
Anwaar Saeed • 13 Nov 2021
1:21
Future directions of CAMILLA trial
Anwaar Saeed • 13 Nov 2021
0:52
Next steps for cabozantinib plus durvalumab in GI cancer
Anwaar Saeed • 13 Nov 2021
View All Videos
1:59
CAR-T therapy for previously treated solid tumors in the digestive tract
Elizabeth C. Smyth • 21 Sep 2021
1:13
Bi-specific antibodies in HER2+ gastric cancer
Hyun C. Chung • 13 Jan 2021
2:26
alloSHRINK: Phase I first-in-human study evaluating CYAD-101, an allogeneic CAR-T in mCRC
Hans Prenen • 22 Jan 2021
View All Videos
1:30
CAMILLA: Combining a VEGF TKI with immune checkpoint inhibitors for GE and GI cancer
Anwaar Saeed • 13 Nov 2021
2:06
CAMILLA: Phase I/II study of cabozantinib plus durvalumab in advanced GE cancer and GI malignancies
Anwaar Saeed • 13 Nov 2021
1:21
Future directions of CAMILLA trial
Anwaar Saeed • 13 Nov 2021
1:57
Results from Phase I/II study of DS-7300a in advanced solid tumors
Melissa Johnson • 6 Oct 2021
View All Videos
1:03
Liquid biopsy: uses and advantages
Heinz-Josef Lenz • 15 Oct 2021
4:08
Challenges in implementing liquid biopsy in colorectal cancer
Heinz-Josef Lenz • 15 Oct 2021
3:12
Liquid biopsy research: CTC lines in colon cancer
Catherine Alix-Panabieres • 21 Oct 2021
3:01
Genomic landscape of late-stage gastric cancer treated with pembrolizumab
Yelena Y. Janjigian • 28 Sep 2021
View All Videos
1:03
Latest developments in radiopharmaceutical therapies
Ian A. Wilson • 12 Nov 2021
1:29
Significance of the gut microbiota on the efficacy of radiotherapy
Chee Kin Then • 1 Nov 2021
0:45
How the gut microbiota can radiosensitize tumors
Chee Kin Then • 1 Nov 2021
3:27
Two-year follow data from the OPERA trial
Jean-Pierre Gerard • 24 Aug 2021
View All Videos

Conferences

ESMO 2021
ESMO WCGIC 2021
ASCO 2021
AACR 2021
ASCO GI 2021
3:01
Genomic landscape of late-stage gastric cancer treated with pembrolizumab
Yelena Y. Janjigian • 28 Sep 2021
3:41
Highlights in gastric cancer from ESMO 2021
Yelena Y. Janjigian • 28 Sep 2021
2:39
DESTINY-Gastric02: 2L T-DXd in HER2+ gastric cancers
Geoffrey Ku • 27 Sep 2021
2:04
Update on the CheckMate649 trial in treatment-naïve GEA
Elizabeth C. Smyth • 21 Sep 2021
View All Videos
2:58
Tislelizumab in patients with unresectable HCC demonstrates durable responses
Ghassan Abou-Alfa • 25 Jun 2021
2:35
Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases
Firas Baidoun • 7 Jul 2021
1:37
Impact of gender and HPV status on anal squamous cell carcinoma survival
Firas Baidoun • 7 Jul 2021
0:40
1L NALIRIFOX in advanced or metastatic PDAC
Zev Wainberg • 1 Jul 2021
View All Videos
1:55
AVANA: preoperative chemo-RT plus avelumab in locally advanced rectal cancer
Lisa Salvatore • 11 Jun 2021
4:24
NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC
Changhoon Yoo • 15 Jun 2021
1:56
Improving outcomes in HCC with immunotherapy
Arndt Vogel • 11 Jun 2021
4:59
CheckMate 648: 1L IO-IO in advanced esophageal squamous cell carcinoma
Ian Chau • 15 Jun 2021
View All Videos
3:05
IMbrave150: updated data on atezo plus bev versus sorafenib in HCC
Peter R. Galle • 20 Apr 2021
2:25
Using oncolytic viruses in solid tumors
Kaidre Bendjama • 15 Apr 2021
4:35
TG6002, an oncolytic virus induces expression of a pro-drug activating enzyme in advanced GI cancers
Kaidre Bendjama • 15 Apr 2021
11:49
Racial differences in somatic mutations among patients with early-onset CRC
Andreana N. Holowatyj • 9 Apr 2021
View All Videos
2:21
Updates in the use of neratinib in fibrolamellar carcinoma and biliary tract cancer
Ghassan Abou-Alfa • 21 Jan 2021
3:02
ASCO GI: IO and interventional oncology
Thomas Helmberger • 22 Jan 2021
4:32
First-line regorafenib 80mg/day with pembrolizumab in advanced HCC
Anthony B. El-Khoueiry • 20 Jan 2021
3:05
Alliance A021501: preoperative mFOLFIRINOX +/- hypofractionated RT for pancreatic cancer
Joshua E. Meyer • 20 Jan 2021
View All Videos
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals